PAI
Palo Alto Investors Portfolio holdings
AUM
$470M
This Quarter Return
+32.21%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$2.4B
AUM Growth
+$2.4B
(+28%)
Cap. Flow
+$104M
Cap. Flow
% of AUM
4.36%
Top 10 Holdings %
Top 10 Hldgs %
68.89%
Holding
38
New
2
Increased
14
Reduced
2
Closed
1
Top Buys
| 1 |
AIMT
Aimmune Therapeutics, Inc.
AIMT
|
$52.8M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
$23M |
| 3 |
Vanda Pharmaceuticals
VNDA
|
$16.5M |
| 4 |
KLDO
Kaleido Biosciences, Inc. Common Stock
KLDO
|
$12.6M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$7.26M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$25.1M |
| 2 |
SHPG
Shire pic
SHPG
|
$8.34M |
| 3 |
MLNT
Melinta Therapeutics, Inc. Common Stock
MLNT
|
$144K |
Sector Composition
| 1 | Healthcare | 89.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Gilead Sciences
GILD
$140B
| $11.4M | 0.48% | 175,900 | – | – |
|
27
Rigel Pharmaceuticals
RIGL
$697M
| $10.2M | 0.43% | 3,985,945 | – | – |
|
|
DRNA
28
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $7.34M | 0.31% | 500,913 | – | – |
|
|
ALIM
29
DELISTED
Alimera Sciences, Inc.
ALIM
| $3.2M | 0.13% | 3,013,793 | – | – |
|
|
ZGNX
30
DELISTED
Zogenix, Inc.
ZGNX
| $1.62M | 0.07% | 29,500 | – | – |
|
|
VIRX
31
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $1.41M | 0.06% | 1,162,473 | – | – |
|
32
Cytokinetics
CYTK
$4.23B
| $1M | 0.04% | 123,686 | – | – |
|
|
MRNS
33
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $477K | 0.02% | +114,221 | New | +$477K |
|
|
SPHS
34
DELISTED
Sophiris Bio, Inc.
SPHS
| $245K | 0.01% | 247,000 | – | – |
|
|
ACGN
35
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $196K | 0.01% | 77,044 | – | – |
|
|
MLNT
36
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
| $36K | ﹤0.01% | 10,137 -40,552 | -80% | -$144K |
|
37
Ocugen
OCGN
$319M
| $35K | ﹤0.01% | 302,922 | – | – |
|
|
SHPG
38
DELISTED
Shire pic
SHPG
| – | – | -47,938 | Closed | -$8.34M |
|